PathoGene
About PathoGene
PathoGene, Inc. is a private, seed-stage precision MedTech startup headquartered in Los Angeles, with R&D operations located in Monrovia, California. We are developing a sample-to-answer in vitro diagnostic medical device that detects and identifies all known microscopic human pathogens along with their antimicrobial resistance profiles on a single 6-hour test panel. To do this, we leverage robotic automation, third-generation DNA and RNA sequencing, and cloud computing technologies to report a molecular diagnosis to care providers and disease surveillance systems in real-time. Our goal is to deliver the necessary diagnostic tools for doctors and medical staff to make optimal treatment decisions that can ultimately improve public health as a whole, and we believe that our sample-to-answer technology can become the global standard of care for diagnosing infectious diseases.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: 500000 USD
- Last Funding: 500000 USD (Seed)
- Funding Status: Seed
Technology Stack
PathoGene actively uses None products in their tech stack.
Market Presence
Industries: Bioinformatics, Biotechnology, Genetics, Health Care, Health Diagnostics, Information Technology, Medical Device
Headquarters: Los Angeles, California, United States
Employees
- John Mickel - Cofounder & Chief Visionary Officer (LinkedIn)